Search Results
Jul 08, 2026, 06:59 ET Bitmine Immersion Technologies (BMNR) annuncia che le sue partecipazioni in ETH raggiungono i 5,74 milioni di token e che le partecipazioni totali in criptovalute e liquidità ammontano a 11,1 miliardi di dollari
continua a essere sostenuta da un gruppo di investitori istituzionali di primario livello, tra cui ARK di Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore privato Thomas "Tom" Lee a sostegno dell'obiettivo di Bitmine di acquisire il 5% di ETH
More news about: Bitmine Immersion Technologies, Inc.
Jul 08, 2026, 06:45 ET BitMine Immersion Technologies (BMNR) anuncia que suas participações em ETH somam 5,74 milhões de tokens e que o total em criptomoedas e caixa é de US$ 11,1 bilhões
Bitmine continua apoiada por um grupo de investidores institucionais de destaque, incluindo Cathie Wood, da ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e o investidor pessoal Thomas "Tom" Lee, para apoiar a meta da Bitmine de adquirir 5% do ETHNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Jul 08, 2026, 06:31 ET Bitmine Immersion Technologies (BMNR) anuncia que sus reservas de ETH alcanzan los 5,74 millones de tokens y que el total de sus activos en criptomonedas y efectivo asciende a 11.100 millones de dólares
respaldo de un grupo de inversionistas institucionales de primer orden, entre los que se incluyen Cathie Wood, de ARK; MOZAYYX; Founders Fund; Bill Miller III; Pantera; Kraken; DCG; Galaxy Digital y el inversionista particular Thomas "Tom" Lee, con el fin de apoyar el objetivo de Bitmine de adquirir el 5 %
More news about: Bitmine Immersion Technologies, Inc.
Jul 08, 2026, 06:30 ET Hyperscale Data Reaffirms 2026 Revenue Guidance of $180 Million to $200 Million and Plans to Hold a Stockholder Conference Call in the Third Quarter to Discuss Ault Capital Group Divestiture and Long-Term Growth Strategy
defined."Our confidence in the future of Hyperscale Data has continued to strengthen during the first half of 2026," said Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "We remain confident in our 2026 revenue guidance of $180 million to $200 million. More importantly, we believe
More news about: Hyperscale Data Inc.
Jul 08, 2026, 03:15 ET WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year
operations, and more efficient manufacturing. As of April 30, 2026, WuXi Biologics is supporting 982 integrated client projects, including 78 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.WuXi Biologics regards
More news about: WuXi Biologics
Jul 07, 2026, 18:16 ET Else Nutrition Announces CSE Listing and Consolidation
(the "Fourth Convertible Security") under the terms of the convertible security funding agreement (the "Agreement") with Lind Global Fund III LP, an entity managed by The Lind Partners, LLC, a New York-based institutional fund manager (together, "Lind"). The Agreement was initially announced
More news about: Else Nutrition Holdings Inc.
Jul 07, 2026, 17:01 ET J&J Exterminating Mourns the Passing of Founder Bobby John Sr
business he founded remains family-owned today, with his values carried forward by a new generation of leadership. Bobby's grandson, Robert Lewis John III, now leads J&J Exterminating.Bobby John Sr. believed deeply in the people who joined his company, often praying for good people to become
More news about: J&J Exterminating
Jul 07, 2026, 16:44 ET NNS erwirbt Anteile an OCI
im Zusammenhang mit dem Erhalt behördlicher Genehmigungen ohne unerwartete Verzögerungen oder Auflagen sowie die Möglichkeit behördlicher Maßnahmen; (iii) Risiken im Zusammenhang mit erheblichen Kosten der Transaktion; (iv) die erwartete finanzielle und operative Entwicklung sowie zukünftige Chancen nach
More news about: NNS Holding (Cyprus) Limited
Jul 07, 2026, 16:42 ET NNS acquiert des actions d'OCI
risques liés à l'obtention des autorisations réglementaires sans retards ni conditions imprévus, ainsi que la possibilité de mesures réglementaires ; (iii) les risques liés aux coûts importants associés à l'opération ; (iv) les performances financières et opérationnelles attendues ainsi que les opportunités
More news about: NNS Holding (Cyprus) Limited
Jul 07, 2026, 15:33 ET GLOBAL BATTERY MATERIALS ANNOUNCES POSITIVE PRELIMINARY ECONOMIC ASSESSMENT FOR THE KEARNEY GRAPHITE PROJECT
particularly at Sheehan; (ii) historical McGuire assay values averaging approximately 15% higher than 2013 verification assays, introducing grade uncertainty; (iii) graphite price volatility driven in part by Chinese oversupply; (iv) dependency on a third-party-funded 44 kV transmission line within 12 months of
More news about: Global Battery Materials
Jul 07, 2026, 15:30 ET Texas Southern University lanza un plan maestro integral para el campus
avanza, es importante que las inversiones en instalaciones e infraestructura respalden los resultados proyectados", dijo el presidente J. W. Crawford III. "El Plan Maestro alinea el desarrollo físico con las prioridades estratégicas institucionales, proporcionando un marco estable que puede ampliarse con
More news about: Texas Southern University
Jul 07, 2026, 13:51 ET NNS acquires shares in OCI
at all; (ii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and the possibility of regulatory action; (iii) risks relating to significant costs related to the transaction; (iv) the expected financial and operating performance and future opportunities following
More news about: NNS Holding (Cyprus) Limited
Jul 07, 2026, 13:45 ET NNS acquires shares in OCI
at all; (ii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and the possibility of regulatory action; (iii) risks relating to significant costs related to the transaction; (iv) the expected financial and operating performance and future opportunities following
More news about: NNS Holding (Cyprus) Limited
Jul 07, 2026, 13:07 ET Texas Southern University Launches Comprehensive Campus Master Plan
University moves forward, it is important that investments in facilities and infrastructure support projected outcomes," said President J. W. Crawford III. "The Master Plan aligns physical development with institutional strategic priorities, providing a stable framework that can be expanded over time."Developed
More news about: Texas Southern University
Jul 07, 2026, 12:12 ET Ondo Perps Launches First Equity Perpetuals Platform With Tokenized Stock Collateral
or operating from a jurisdiction subject to the international sanctions regimes maintained by the UN, Panama, US, EU, UK, or Canada, as applicable; (iii) persons or entities that are located in, incorporated in, organized in, or operating from Panama, the US (or any of its states, possessions, territories
More news about: Ondo Finance
Jul 07, 2026, 10:31 ET Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight
the last participant had been randomized and dosed in the pivotal Phase III (LUCIDITY) clinical trial of avexitide in PBH.In March 2026, Amylyx Pharmaceuticals announced that the topline results from the Phase III (LUCIDITY) evaluating avexitide in PBH are anticipated in Q3 2026, and if
More news about: DelveInsight Business Research, LLP
Jul 07, 2026, 10:00 ET The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials
to Innovative TherapiesOne early example of the alliance's impact is the selection of UCHealth University of Colorado Hospital as a Phase III clinical trial site for an investigational cellular therapy for advanced Parkinson's disease. The study will leverage the expertise of CU Anschutz neurologists
More news about: University of Colorado Anschutz
Jul 07, 2026, 09:43 ET Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
partners of MMAI Gym.About the Phase III Clinical TrialThe Phase III clinical trial will evaluate Rentosertib in patients with idiopathic pulmonary fibrosis. The prospective, randomized, double-blind, placebo-controlled, parallel-group Phase III study is expected to enroll a total of 320
More news about: Insilico Medicine
Jul 07, 2026, 09:23 ET Bitmine Immersion Technologies (BMNR) Umumkan Kepemilikan ETH Mencapai 5,74 Juta Token dan Total Kepemilikan Kripto Maupun Total Uang Tunai Sebesar $11,1 Miliar
Bitmine tetap didukung oleh kelompok penting beranggotakan investor institusi seperti Cathie Wood dari ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital, serta investor pribadi Thomas "Tom" Lee guna mendukung tujuan Bitmine untuk mengakuisisi 5% ETH
More news about: Bitmine Immersion Technologies, Inc.
Jul 07, 2026, 09:00 ET As Canada Highlights Fusion in Its Nuclear Energy Strategy, Shareholders Vote to Take a Fusion Pioneer Public
Issued on behalf of General Fusion Inc.Spring Valley Acquisition Corp. III (NASDAQ: SVAC) completed its shareholder vote July 6, 2026 approving the business combination with General Fusion Inc., which at closing would create the combined entity General Fusion Group Ltd. and, subject
More news about: American News Group
Jul 07, 2026, 09:00 ET Levi & Korsinsky, LLP Announces Notice of Pendency and Proposed Settlement of Class Action for All Persons Who Purchased or Otherwise Acquired DZS Inc. Common Stock Between May 4, 2022, and November 9, 2023, Inclusive
inclusive, and were damaged thereby. Excluded from the Class are (i) Defendants and members of their immediate families; (ii) DASAN Networks, Inc. ("DNI"); (iii) the officers and directors of DZS and DNI during the Class Period, and their immediate families; (iv) the legal representatives, heirs, successors,
More news about: Levi & Korsinsky, LLP
Jul 07, 2026, 08:00 ET INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead the Grail Class Action Lawsuit
reduction in Stage III-IV cancers in Grail's NHS-Galleri trial, while also concealing material adverse facts which reduced the possibility of such an outcome; (ii) in truth, Grail's optimism in achieving the primary endpoint of its NHS-Galleri study fell short of reality; and (iii) the confidence management
More news about: Robbins Geller Rudman & Dowd LLP
Jul 07, 2026, 07:50 ET Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio
maintain sufficient manufacturing capability, personnel, equipment, quality systems and regulatory compliance to support anticipated production volumes; (iii) the Company's technologies, formulations and intellectual property will perform substantially as expected; (iv) commercialization initiatives will proceed
More news about: Vector Sciences & Therapeutics
Jul 07, 2026, 06:36 ET GRAL Investment Deadline: GRAIL, Inc. Securities Fraud Class Action Focuses on Trial Results; Investors Notified of August 4 Court Deadline
Health Service ("NHS"), GRAIL conducted the "NHS-Galleri trial." The primary objective of the NHS-Galleri trial was "to show a reduction in late-stage (III-IV) cancers in people who received the Galleri test compared with those who did not."According to the complaint, during the relevant period, GRAIL
More news about: Bleichmar Fonti & Auld LLP
Jul 07, 2026, 06:35 ET INVESTOR DEADLINE: RGRD Law Announces that Commvault Systems, Inc. (CVLT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Lead Plaintiff Deadline is July 17, 2026
throughout fiscal year 2026; (ii) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; and (iii) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, Commvault's projected net new ARR should not have been
More news about: Robbins Geller Rudman & Dowd LLP